Sources | Names Used |
---|---|
CTRPv2 | tanespimycin:bortezomib (250:1 mol/mol) |
PharmacoGx | tanespimycin:bortezomib (250:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SRP9 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
mRNA | CYTH3 | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-05 |
mRNA | TTC38 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
mRNA | ANKRD6 | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |
mRNA | FBXO28 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
mRNA | MB21D1 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |
mRNA | GOLGA2 | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-05 |
mRNA | CNOT9 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-05 |
mRNA | RPAP2 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
mRNA | VIPR1 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |